Literature DB >> 23212909

The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia.

Tian Xia1, Laurence Lévy, Florence Levillayer, Baosen Jia, Gaiyun Li, Christine Neuveut, Marie-Annick Buendia, Ke Lan, Yu Wei.   

Abstract

Arkadia is a RING-based ubiquitin ligase that positively regulates TGF-β signaling by targeting several pathway components for ubiquitination and degradation. However, little is known about the mechanisms controlling Arkadia activity. Here we show that the LIM-only protein FHL2 binds and synergistically cooperates with Arkadia to activate Smad3/Smad4-dependent transcription. Knockdown of FHL2 by RNA interference decreases Arkadia level and restricts the amplitude of Arkadia-induced TGF-β target gene responses. We found that Arkadia is ubiquitinated via K63- and K27-linked polyubiquitination. A single mutation at the RING domain that abolishes the E3 activity diminishes Arkadia ubiquitination, indicating that this modification partly involves autocatalytic process. Mutation of seven lysines at the C-terminal region of Arkadia severely impairs ubiquitination through the K27 but not the K63 linkage and slows down the turnover of Arkadia, suggesting that K27-linked polyubiquitination might promote proteolysis-dependent regulation of Arkadia. We show that FHL2 increases the half-life of Arkadia through inhibition of ubiquitin chain assembly on the protein, which provides a molecular basis for functional cooperation between Arkadia and FHL2 in enhancing TGF-β signaling. Our study uncovers a novel regulatory mechanism of Arkadia by ubiquitination and identifies FHL2 as important regulator of Arkadia ubiquitination and TGF-β signal transduction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212909      PMCID: PMC3548488          DOI: 10.1074/jbc.M112.439760

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  FHL2, a novel tissue-specific coactivator of the androgen receptor.

Authors:  J M Müller; U Isele; E Metzger; A Rempel; M Moser; A Pscherer; T Breyer; C Holubarsch; R Buettner; R Schüle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Analysis of protein ubiquitination.

Authors:  Jeffrey D Laney; Mark Hochstrasser
Journal:  Curr Protoc Protein Sci       Date:  2011-11

Review 3.  RING domain E3 ubiquitin ligases.

Authors:  Raymond J Deshaies; Claudio A P Joazeiro
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 4.  Nonproteolytic functions of ubiquitin in cell signaling.

Authors:  Zhijian J Chen; Lijun J Sun
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

5.  Nuclear signalling by tumour-associated antigen EpCAM.

Authors:  Dorothea Maetzel; Sabine Denzel; Brigitte Mack; Martin Canis; Philip Went; Michael Benk; Cuong Kieu; Peer Papior; Patrick A Baeuerle; Markus Munz; Olivier Gires
Journal:  Nat Cell Biol       Date:  2009-01-11       Impact factor: 28.824

Review 6.  The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation.

Authors:  Allan M Weissman; Nitzan Shabek; Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-23       Impact factor: 94.444

7.  Degradation of CFTR by the ubiquitin-proteasome pathway.

Authors:  C L Ward; S Omura; R R Kopito
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

8.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

9.  Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.

Authors:  Lihua Ding; Zhaoyun Wang; Jinghua Yan; Xiao Yang; Aijun Liu; Weiyi Qiu; Jianhua Zhu; Juqiang Han; Hao Zhang; Jing Lin; Long Cheng; Xi Qin; Chang Niu; Bin Yuan; Xiaohui Wang; Cui Zhu; Yan Zhou; Jiezhi Li; Haifeng Song; Cuifen Huang; Qinong Ye
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

10.  Lysosomal localization of ubiquitinated Jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate.

Authors:  Hiromi Ikeda; Tom K Kerppola
Journal:  Mol Biol Cell       Date:  2008-08-20       Impact factor: 4.138

View more
  12 in total

1.  Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.

Authors:  Qiang Wang; Xiaoying Wang; Xiufen Tian; Ronghua Tang; Xin Xu
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

2.  LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression.

Authors:  Jennifer Dahan; Florence Levillayer; Tian Xia; Yann Nouët; Catherine Werts; Martine Fanton d'Andon; Minou Adib-Conquy; Anne-Marie Cassard-Doulcier; Varun Khanna; Ju Chen; Thierry Tordjmann; Marie-Annick Buendia; Grégory Jouvion; Yu Wei
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

3.  PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells.

Authors:  Yueli Shi; Xinyu Wang; Zhiyong Xu; Ying He; Chunyi Guo; Lingjuan He; Caijuan Huan; Changhong Cai; Jiaqi Huang; Jie Zhang; Yiqing Li; Chunlai Zeng; Xue Zhang; Linrun Wang; Yuehai Ke; Hongqiang Cheng
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

4.  LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis.

Authors:  Jennifer Dahan; Yann Nouët; Grégory Jouvion; Florence Levillayer; Minou Adib-Conquy; Anne-Marie Cassard-Doulcier; Ali Tebbi; Fany Blanc; Lauriane Remy; Ju Chen; Stefano Cairo; Catherine Werts; Mustapha Si-Tahar; Thierry Tordjmann; Marie-Annick Buendia; Yu Wei
Journal:  Mol Cell Biol       Date:  2013-06-17       Impact factor: 4.272

5.  Multiple Arkadia/RNF111 structures coordinate its Polycomb body association and transcriptional control.

Authors:  Huaiyu Sun; Yijing Liu; Tony Hunter
Journal:  Mol Cell Biol       Date:  2014-06-09       Impact factor: 4.272

6.  Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells.

Authors:  Jiaying Xu; Junwei Zhou; Man-Shan Li; Chor-Fung Ng; Yuen-Keng Ng; Paul Bo-San Lai; Stephen Kwok-Wing Tsui
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

7.  The complex of TRIP-Br1 and XIAP ubiquitinates and degrades multiple adenylyl cyclase isoforms.

Authors:  Wenbao Hu; Xiaojie Yu; Zhengzhao Liu; Ying Sun; Xibing Chen; Xin Yang; Xiaofen Li; Wai Kwan Lam; Yuanyuan Duan; Xu Cao; Hermann Steller; Kai Liu; Pingbo Huang
Journal:  Elife       Date:  2017-06-28       Impact factor: 8.140

8.  Molecular Analysis of a Short-term Model of β-Glucans-Trained Immunity Highlights the Accessory Contribution of GM-CSF in Priming Mouse Macrophages Response.

Authors:  Sarah Walachowski; Guillaume Tabouret; Marion Fabre; Gilles Foucras
Journal:  Front Immunol       Date:  2017-09-11       Impact factor: 7.561

9.  LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis.

Authors:  Chantal Kroone; Mariska Vos; Timo Rademakers; Marijke Kuijpers; Mark Hoogenboezem; Jaap van Buul; Johan W M Heemskerk; Wolfram Ruf; Astrid van Hylckama Vlieg; Henri H Versteeg; Marie-José Goumans; Carlie J M de Vries; Kondababu Kurakula
Journal:  Haematologica       Date:  2019-08-29       Impact factor: 9.941

10.  Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer.

Authors:  L Verset; J Tommelein; X Moles Lopez; C Decaestecker; M Mareel; M Bracke; I Salmon; O De Wever; P Demetter
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.